Thermo Fisher Scientific (TMO) 재무상태표
NYSE · Healthcare · Medical - Diagnostics & Research · 직원 125,000명 · CEO Marc N. Casper
- 주가
- $697.00 -1.72%
- 시가총액
- $2580억
- 기업가치
- $2940억
- 최근 실적
- Q3 '26 2026-10-30 제출
- 다음 실적
- 2027-02-04 EPS 추정 $7.13
Thermo Fisher Scientific (TMO)의 Q3 '26말 현금 및 단기투자는 $60.6억, 리스 포함 차입금은 $414억입니다. 자산총계 $1140억, 부채총계 $595억, 주주지분 $548억.
재무상태표
| 재무상태표 | 추세 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $80.8억 | $55.1억 | $70.8억 | $46.5억 | $40.2억 | $41.3억 | $45.8억 | $19.8억 | $98.5억 | $32.5억 | $40.6억 | $54.6억 | |
| 단기투자 | $0 | $17.5억 | $17.5억 | $20억 | $15.6억 | $18.1억 | $18.1억 | $15.6억 | $2.53억 | $200만 | $0 | $6억 | |
| 매출채권 | $96.6억 | $93.5억 | $94.3억 | $98억 | $96.3억 | $98.2억 | $100억 | $105억 | $106억 | $109억 | $94.5억 | $96.3억 | |
| 재고자산 | $50.9억 | $51.3억 | $52억 | $54.3억 | $49.8억 | $52.2억 | $55.6억 | $57.5억 | $54.3억 | $55억 | $56.3억 | $56.4억 | |
| 기타 유동자산 | $17.6억 | $19억 | $20.3억 | $19.1억 | $19.5억 | $23.9억 | $26억 | $24.7억 | $26.1억 | $26.8억 | $42.2억 | $42.9억 | |
| 유동자산 | $246억 | $236억 | $255억 | $238억 | $221억 | $234억 | $246억 | $223억 | $287억 | $223억 | $234억 | $256억 | |
| 유형자산(순액) | $110억 | $93.2억 | $92.8억 | $94.1억 | $108억 | $93.3억 | $96.4억 | $102억 | $106억 | $107억 | $108억 | $106억 | |
| 장기투자 | $5900만 | $2.33억 | $4.92억 | $1.06억 | $5.6억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 영업권 | $440억 | $438억 | $438억 | $467억 | $459억 | $465억 | $472억 | $493억 | $494억 | $552억 | $548억 | $543억 | |
| 무형자산 | $167억 | $160억 | $155억 | $163억 | $155억 | $153억 | $151억 | $162억 | $158억 | $191억 | $186억 | $181억 | |
| 기타 비유동자산 | $23.8억 | $40.1억 | $38.8억 | $40.8억 | $24.4억 | $45.2억 | $46.2억 | $50.2억 | $58.7억 | $59.7억 | $56.2억 | $57억 | |
| 비유동자산 | $741억 | $735억 | $730억 | $766억 | $752억 | $757억 | $766억 | $807억 | $816억 | $910억 | $898억 | $886억 | |
| 자산총계 | $987억 | $971억 | $985억 | $1000억 | $973억 | $990억 | $1010억 | $1030억 | $1100억 | $1130억 | $1130억 | $1140억 | |
| 부채 | |||||||||||||
| 매입채무 | $28.7억 | $25.6억 | $25.5억 | $26.1억 | $30.8억 | $30.5억 | $29.8억 | $31.2억 | $36.2억 | $33.4억 | $32.7억 | $0 | |
| 미지급비용 | $16억 | $13.1억 | $15억 | $18.2억 | $19.9억 | $44.4억 | $47.2억 | $50.9억 | $53.2억 | $52.6억 | $55.2억 | $0 | |
| 단기차입금 | $38.7억 | $44.5억 | $51.2억 | $41.2억 | $24.8억 | $28.2억 | $22.1억 | $38.2억 | $35.3억 | $30.9억 | $33.7억 | $22.6억 | |
| 이연수익 | $26.9억 | $26.3억 | $25.9억 | $26.6억 | $28.5억 | $28.7억 | $28.1억 | $28.5억 | $27.1억 | $29.3억 | $29.2억 | $0 | |
| 기타 유동부채 | $29.8억 | $29.9억 | $30.2억 | $33.9억 | $29.4억 | -$100만 | $100만 | $0 | $0 | $0 | -$200만 | $119억 | |
| 유동부채 | $140억 | $139억 | $148억 | $146억 | $133억 | $132억 | $127억 | $149억 | $152억 | $146억 | $151억 | $142억 | |
| 장기차입금 | $313억 | $312억 | $303억 | $312억 | $291억 | $314억 | $330억 | $319억 | $359억 | $401억 | $392억 | $391억 | |
| 리스부채(비유동) | $12.4억 | $0 | $0 | $0 | $12.4억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 이연수익(비유동) | $15억 | $14.3억 | $14.6억 | $14.3억 | $11.4억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 이연법인세부채 | $19.2억 | $18.1억 | $15.2억 | $11.2억 | $12.7억 | $10.4억 | $6.24억 | $8.42억 | $14.9억 | $21.1억 | $15.8억 | $14.7억 | |
| 기타 비유동부채 | $19억 | $31.4억 | $29.4억 | $29.2억 | $16.1억 | $39.7억 | $42.7억 | $42.8억 | $42.7억 | $44.2억 | $45.4억 | $47.2억 | |
| 비유동부채 | $379억 | $375억 | $362억 | $367억 | $343억 | $364억 | $379억 | $370억 | $416억 | $466억 | $453억 | $453억 | |
| 부채총계 | $519억 | $515억 | $510억 | $513억 | $477억 | $496억 | $506억 | $519억 | $568억 | $612억 | $605억 | $595억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $4.42억 | $4.43억 | $4.43억 | $4.44억 | $4.44억 | $4.44억 | $4.44억 | $4.45억 | $4.45억 | $4.45억 | $4.46억 | $4.47억 | |
| 이익잉여금 | $474억 | $485억 | $499억 | $514억 | $531억 | $544억 | $559억 | $574억 | $592억 | $606억 | $622억 | $637억 | |
| 기타포괄손익누계액 | -$32.2억 | -$27.6억 | -$24.1억 | -$24.8억 | -$27억 | -$23.4억 | -$28억 | -$28억 | -$24.5억 | -$25억 | -$24.6억 | -$22.6억 | |
| 주주지분 | $467억 | $455억 | $474억 | $490억 | $496억 | $494억 | $505억 | $510억 | $534억 | $519억 | $527억 | $548억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $364억 | $356억 | $354억 | $353억 | $328억 | $342억 | $352억 | $357억 | $394억 | $432억 | $425억 | $414억 | |
| 순차입금(차입금 - 현금) | $283억 | $301억 | $283억 | $307억 | $288억 | $301억 | $307억 | $337억 | $295억 | $399억 | $385억 | $359억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $7.86억 | $13.4억 | $21억 | $24억 | $103억 | $44.8억 | $85.2억 | $80.8억 | $40.2억 | $98.5억 | |
| 단기투자 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $15.6억 | $2.53억 | |
| 매출채권 | $30.5억 | $38.8억 | $46억 | $49.5억 | $64.7억 | $89.5억 | $94.3억 | $96.6억 | $96.3억 | $106억 | |
| 재고자산 | $22.1억 | $29.7억 | $30.1억 | $33.7억 | $40.3억 | $50.5억 | $56.3억 | $50.9억 | $49.8억 | $54.3억 | |
| 기타 유동자산 | $9.73억 | $12.4억 | $9.22억 | $11.7억 | $11.3억 | $16.4억 | $16.4억 | $17.6억 | $19.5억 | $26.1억 | |
| 유동자산 | $70.2억 | $94.2억 | $106억 | $119억 | $220억 | $201억 | $252억 | $246억 | $221억 | $287억 | |
| 유형자산(순액) | $25.8억 | $40.5억 | $41.7억 | $54.5억 | $66.9억 | $98.6억 | $109억 | $110억 | $108억 | $106억 | |
| 장기투자 | $3700만 | $3400만 | $5300만 | $3500만 | $6500만 | $7300만 | $1.55억 | $5900만 | $5.6억 | $0 | |
| 영업권 | $213억 | $253억 | $253억 | $257억 | $260억 | $419억 | $412억 | $440억 | $459억 | $494억 | |
| 무형자산 | $140억 | $167억 | $150억 | $140억 | $127억 | $201억 | $175억 | $167억 | $155억 | $158억 | |
| 기타 비유동자산 | $9.75억 | $11.9억 | $10.6억 | $12.8억 | $15.7억 | $30억 | $22.2억 | $23.8억 | $24.4억 | $58.7억 | |
| 비유동자산 | $389억 | $472억 | $456억 | $465억 | $471억 | $750억 | $719억 | $741억 | $752억 | $816억 | |
| 자산총계 | $459억 | $567억 | $562억 | $584억 | $691억 | $951억 | $972억 | $987억 | $973억 | $1100억 | |
| 부채 | |||||||||||
| 매입채무 | $9.26억 | $14.3억 | $16.2억 | $19.2억 | $21.8억 | $28.7억 | $33.8억 | $28.7억 | $30.8억 | $36.2억 | |
| 미지급비용 | $7.09억 | $9.18억 | $9.82억 | $10.1억 | $19.2억 | $24.3억 | $21억 | $16억 | $19.9억 | $53.2억 | |
| 단기차입금 | $12.6억 | $21.4억 | $12.7억 | $8.43억 | $28.1억 | $28억 | $58.5억 | $38.7억 | $24.8억 | $35.3억 | |
| 미지급세금 | $1.65억 | $4.32억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 이연수익 | $4.86억 | $7.19억 | $8.09억 | $9.16억 | $12.7억 | $26.6억 | $26억 | $26.9억 | $28.5억 | $27.1억 | |
| 기타 유동부채 | $13.2억 | $18.5억 | $14.7억 | $15.1억 | $21.3억 | $26.8억 | $30.8억 | $29.8억 | $29.4억 | $0 | |
| 유동부채 | $48.7억 | $70.5억 | $61.5억 | $62억 | $103억 | $134억 | $170억 | $140억 | $133억 | $152억 | |
| 장기차입금 | $155억 | $189억 | $177억 | $171억 | $191억 | $321억 | $289억 | $313억 | $291억 | $359억 | |
| 리스부채(비유동) | $1030만 | $1000만 | $900만 | $5.71억 | $6.26억 | $13.9억 | $13.1억 | $12.4억 | $12.4억 | $0 | |
| 이연수익(비유동) | $0 | $0 | $3.55억 | $5.94억 | $7.63억 | $12.4억 | $11.8억 | $15억 | $11.4억 | $0 | |
| 이연법인세부채 | $25.6억 | $27.7억 | $22.7억 | $21.9억 | $17.9억 | $38.4억 | $28.5억 | $19.2억 | $12.7억 | $14.9억 | |
| 기타 비유동부채 | $15.7억 | $25.7억 | $21.6억 | $20.8억 | $19.4억 | $21억 | $17.5억 | $19억 | $16.1억 | $42.7억 | |
| 비유동부채 | $195억 | $242억 | $225억 | $225억 | $242억 | $407억 | $360억 | $379억 | $343억 | $416억 | |
| 부채총계 | $244억 | $313억 | $286억 | $287억 | $345억 | $541억 | $530억 | $519억 | $477억 | $568억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $4.15억 | $4.28억 | $4.32억 | $4.34억 | $4.37억 | $4.39억 | $4.41억 | $4.42억 | $4.44억 | $4.45억 | |
| 이익잉여금 | $139억 | $159억 | $187억 | $221억 | $281억 | $354억 | $419억 | $474억 | $531억 | $592억 | |
| 기타포괄손익누계액 | -$26.4억 | -$20억 | -$25억 | -$26.8억 | -$28.1억 | -$23.3억 | -$31억 | -$32.2억 | -$27억 | -$24.5억 | |
| 주주지분 | $215억 | $254억 | $276억 | $297억 | $345억 | $408억 | $440억 | $467억 | $496억 | $534억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $166억 | $210억 | $190억 | $185억 | $225억 | $363억 | $361억 | $364억 | $328억 | $394억 | |
| 순차입금(차입금 - 현금) | $158억 | $196억 | $169억 | $161억 | $122억 | $319억 | $275억 | $283억 | $288억 | $295억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-09-26, 10-Q 2026-06-27, 10-Q 2026-03-28, 10-K 2025-12-31, 10-Q 2025-09-27, 10-Q 2025-06-28, 10-Q 2025-03-29, 10-K 2024-12-31, 10-Q 2024-09-28
데이터 기준일 2026-11-01